Korsching, S, and H Thoenen.
"Treatment with 6-hydroxydopamine and colchicine decreases nerve growth factor levels in sympathetic ganglia and increases them in the corresponding target tissues." Journal of Neuroscience
5.4
(1985):
1058-1061.
Web. 18 April. 2024.